1,472
Views
0
CrossRef citations to date
0
Altmetric
Technical report

A case-control study of bleeding risk in children with 22q11.2 deletion syndrome undergoing cardiac surgery

, , , , , , , , & show all
Article: 2290108 | Received 21 Aug 2023, Accepted 27 Nov 2023, Published online: 15 Dec 2023

References

  • Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O’Leary LA, Wong L-Y, Elixson EM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003 Jul;112(1):101–7. doi:10.1542/peds.112.1.101.
  • Tezenas Du Montcel S, Mendizabai H, Ayme S, Levy A, Philip N. Prevalence of 22q11 microdeletion. J Med Genet. 1996 Aug;33(8):719. doi:10.1136/jmg.33.8.719.
  • Blagojevic C, Heung T, Theriault M, Tomita-Mitchell A, Chakraborty P, Kernohan K, Bulman DE, Bassett AS. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening. CMAJ Open. 2021 Jul-Sep;9(3):E802–E809. doi:10.9778/cmajo.20200294.
  • McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JAS, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. Nov 19 2015;1(1):15071. doi:10.1038/nrdp.2015.71.
  • Cirillo A, Lioncino M, Maratea A, Passariello A, Fusco A, Fratta F, Monda E, Caiazza M, Signore G, Esposito A, et al. Clinical manifestations of 22q11.2 deletion syndrome. Heart Fail Clin. 2022 Jan;18(1):155–64. doi:10.1016/j.hfc.2021.07.009.
  • Brenner MK, Clarke S, Mahnke DK, Simpson P, Bercovitz RS, Tomita-Mitchell A, Mitchell ME, Newman DK. Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery. Pediatr Res. 2016 Feb;79(2):318–24. doi:10.1038/pr.2015.216.
  • O’Brien SM, Jacobs JP, Pasquali SK, Gaynor JW, Karamlou T, Welke KF, Filardo G, Han JM, Kim S, Shahian DM, et al. The society of thoracic surgeons congenital heart surgery database mortality risk model: part 1—statistical methodology. Ann Thorac Surg. 2015 Sep;100(3):1054–62. doi:10.1016/j.athoracsur.2015.07.014.
  • Butt W. Bleeding after cardiac surgery: multiple strategies and teamwork are essential! Perfusion. 2019 Nov;34(8):637–9. doi:10.1177/0267659119867196.
  • Willems A, Patte P, De Groote F, Van der Linden P. Cyanotic heart disease is an independent predicting factor for fresh frozen plasma and platelet transfusion after cardiac surgery. Transfus Apher Sci. 2019 Jun;58(3):304–9. doi:10.1016/j.transci.2019.03.014.
  • Ali U, Goldenberg N, Foreman C, Lynn LC, Honjo O., O’Leary J, Faraoni D. Association between cyanosis, transfusion, and thrombotic complications in neonates and children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2020 Feb;34(2):349–355. doi:10.1053/j.jvca.2019.07.123.
  • Faraoni D, Emani S, Halpin E, Bernier R, Emani SM, DiNardo JA, Ibla JC. Relationship between transfusion of blood products and the incidence of thrombotic complications in neonates and infants undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2017 Dec;31(6):1943–1948. doi:10.1053/j.jvca.2017.04.039.
  • Agarwal HS, Barrett SS, Barry K, Xu M, Saville BR, Donahue BS, Harris ZL, Bichell DP. Association of blood products administration during cardiopulmonary bypass and excessive post-operative bleeding in pediatric cardiac surgery. Pediatr Cardiol. 2015 Mar;36(3):459–67. doi:10.1007/s00246-014-1034-z.
  • Patel PO, Baylis AL, Hickey SE, Stanek J, Kirschner RE, Rand ML, Kumar R. Bleeding severity and phenotype in 22q11.2 deletion syndrome—a cross-sectional investigation. J Pediatr. 2021 Aug;235:220–225. doi:10.1016/j.jpeds.2021.03.071.
  • Bonati MT, Vanelli C, Sangalli D, Sina C, Giardino D, Sassone J, Girotti F, Silani V, Ciammola A. Cerebral microbleeds: a new presenting feature of chromosome 22q11.2 deletion syndrome. J Neurol Sci. 2016 Sep 15; 368:300–3. doi:10.1016/j.jns.2016.07.044.
  • Rosa RF, Rosa RC, Dos Santos PP, Zen PR, Paskulin GA. Hematological abnormalities and 22q11.2 deletion syndrome. Rev Bras Hematol Hemoter. 2011;33(2):151–4. doi:10.5581/1516-8484.20110037.
  • Pekelharing J, Furck A, Banya W, Macrae D, Davidson SJ. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit. Int J Lab Hematol. 2014 Aug;36(4):465–71. doi:10.1111/ijlh.12171.
  • Jyonouchi S, McDonald-McGinn DM, Bale S, Zackai EH, Sullivan KE. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009 May;123(5):e871–7. doi:10.1542/peds.2008-3400.
  • Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003 Aug;143(2):277–8. doi:10.1067/S0022-3476(03)00248-8.
  • Kratz CP, Niehues T, Lyding S, Heusch A, Janssen G, Gobel U. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr Hematol Oncol. 2003 Mar;20(2):167–72. doi:10.1080/0880010390158685.
  • Budarf ML, Konkle BA, Ludlow LB, Michaud D, Li M, Yamashiro DJ, McDonald-McGinn D, Zackai EH, Driscoll DA. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. Hum Mol Genet. 1995 Apr;4(4):763–6. doi:10.1093/hmg/4.4.763.
  • Campbell IM, Crowley TB, Jobaliya C, Bailey A, McGinn DE, Gaiser K, Bassett A, Gur RE, Morrow B, Emanuel BS, et al. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression. Clin Genet. 2023 Jan;103(1):109–13. doi:10.1111/cge.14227.
  • Arganbright JM, Hankey PB, Tracy M, Narayanan S, Noel-MacDonnell J, Ingram D. Tonsillectomy in children with 22q11.2 deletion syndrome. Genes (Basel). 2022 Nov 23; 13(12):2187. doi:10.3390/genes13122187.